Successful treatment of transient acquired factor X deficiency by plasmapheresis with concomitant intravenous immunoglobulin and steroid therapy

American Journal of Hematology

Volumn 57, Issue 3, 1998, Pages 245-252

  Smith, S V ^a   Lues, D K ^a   White II, G C ^a   Brecher, M E ^a  

^a UNIVERSITY OF NORTH CAROLINA HOSPITALS   (United States)

Author keywords

Factor X deficiency; Inhibitor; Plasmapheresis

Indexed keywords

BLOOD CLOTTING FACTOR 7A; FRESH FROZEN PLASMA; IMMUNOGLOBULIN; METHYLPREDNISOLONE; PREDNISONE; SNAKE VENOM; THROMBOPLASTIN;

ADULT; AGED; ARTICLE; BLEEDING TENDENCY; BLOOD CLOTTING FACTOR 10 DEFICIENCY; CASE REPORT; CORTICOSTEROID THERAPY; FEMALE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MALE; ORAL DRUG ADMINISTRATION; PARTIAL THROMBOPLASTIN TIME; PLASMAPHERESIS; PRIORITY JOURNAL; PROTHROMBIN TIME;

ADULT; AGED; ANTI-INFLAMMATORY AGENTS; BLOOD PLATELETS; FACTOR X; FACTOR X DEFICIENCY; FEMALE; HUMANS; IMMUNOGLOBULIN G; MALE; METHYLPREDNISOLONE; PLASMAPHERESIS; PLATELET AGGREGATION INHIBITORS; PREDNISONE; PROTHROMBIN TIME;

EID: 2642708344     PISSN: 03618609     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-8652(199803)57:3<245::AID-AJH13>3.0.CO;2-9     Document Type: Article

References (21)

1. Furie B, Voo L, McAdam KPWJ, Furie BC: Mechanism of factor X deficiency in systemic amyloidosis. New Engl J Med 304:827-830, 1981.
2. Griepp PR, Kyle RA, Bowie EJW: Factor X deficiency in amyloidosis: A critical review. Am J Hematol 11:443-450, 1981.
3. Stefanini M, Wiggishoff CC: Stuart Factor (factor X) deficiency associated with renal and adrenal cortical insufficiency. Ann Intern Med 64:1285-1291, 1966.
4. Carter C, Winfield DA: Factor X deficiency during treatment of relapsed acute myeloid leukemia with amsacrine. Clin Lab Hematol 10:225-228, 1988.
5. Caimi MT, Redaelli R, Cattaneo D, Nosari AM, Baudo F, de Cataldo F: Acquired selective factor X deficiency in acute nonlymphocytic leukemia. Am J Hematol 36:65-66, 1991.
6. Pabinger I, Bettelheim P, Dudczak R, Hinterberger W, Kyrle PA, Niessner H, Schwarzinger I, Speiser W, Lechner K: Coincidence of acquired factor-X deficiency and disseminated intravascular coagulation in patients with acute nonlymphocytic leukemia. Ann Hematol 62:174-179, 1991.
7. Korte W, Flury R: Acquired factor X deficiency and disseminated intravascular coagulation in a case of metastasizing carcinoma of the stomach and its course under chemotherapy. Ann Hematol 64:152-154, 1992.
8. Graham JB, Barrow EM, Wynne TR: Stuart clotting defect. III. An acquired case with complete recovery. In Brinkhous KM (ed): "Hemophilia and Other Hemorrhagic States, International Symposium Rome." Chapel Hill, NC: University of North Carolina Press, 1959, pp 158-166.
9. Bayer WL, Curiel D, Szeto ILF, Lewis JH: Acquired factor X deficiency in a negro boy. Pediatrics 44:1007-1009, 1969.
10. Peuscher FW, van Aken WG, van Mourik JA, Swaak AJG, Sie LH, van Eps LWS: Acquired, transient factor X (Stuart Factor) deficiency in a patient with mycoplasma pneumonial infection. Scand J Haematol 23:257-264, 1979.
11. Edgin RA, Metz EN, Fromkes JJ, Beman FM: Acquired factor X deficiency with associated defects in platelet aggregation. Am J Med 69:137-139, 1980.
12. Bayer WL, Borek D, Chandramohan M, Jenkins DC, Plapp FV: Acquired idiopathic factor X deficiency. Blood 60(Suppl):207A, 1982.
13. Hosker JP, Jewell DP: Transient, selective factor X deficiency and acute liver failure following chest infection treated with erythromycin BP. Postgrad Med J 59:514-515, 1983.
14. Currie MS, Stein AM, Rustagi PK, Behrens AR, Logue GL: Transient acquired factor X deficiency associated with pneumonia. NY State J Med 84:572-573, 1984.
15. Henson K, Files JC, Morrison FS: Transient acquired factor X deficiency: Report of the use of activated clotting concentrate to control a life-threatening hemorrhage. Am J Med 87:583-585, 1989.
16. Mulhare PE, Tracy PB, Golden EA, Branda RF, Bovill EG: A case of acquired factor X deficiency with in vivo and in vitro evidence of inhibitor activity directed against factor X. Coag Transfus Med 96: 196-200, 1991.
17. Lankiewicz MW, Bell WR: A unique circulating inhibitor with specificity for coagulation factor X. Am J Med 93:343-346, 1992.
18. Rao LVM, Zivelin A, Iturbe I, Rapaport SI: Antibody-induced acute factor X deficiency: Clinical manifestations and properties of the antibody. Thromb Haemost 72:363-371, 1994.
19. Chavin SI, Siegel DM, Rocco Jr TA, Olson JP: Acute myocardial infarction during treatment with an activated prothrombin complex concentrate in a patient with factor VIII deficiency and a factor VIII inhibitor. Am J Med 85:245-249, 1988.
20. Christolini A, Mazzucconi MG, Tirindelli MC, La Verde G, Ferrari A, Mandelli F: Disseminated intravascular coagulation and myocardial infarction in a haemophilia B patient during therapy with prothrombin complex concentrates. Acta Haematol 83:163-165, 1990.
21. Blatt PM, Lundblad RL, Kingdon HS, McLean G, Roberts HR: Thrombogenic materials in prothrombin complex concentrates. Ann Intern Med 81:766-770, 1974.